When was Portal Biotech founded?

Portal Biotech was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Portal Biotech located?

Portal Biotech is headquartered in London, United Kingdom. It is registered at 38 SWINBURNE ROAD,ABINGDON,ENGLAND,OX14 2HD.

Who is the current CEO of Portal Biotech?

Andrew Heron of Portal Biotech. They have also founded 1 company and are an angel investors in 1 startup.

Which legal entities is Portal Biotech associated with?

Portal Biotech is associated with PORTAL BIOTECH LIMITED.

How many employees does Portal Biotech have?

As of Mar 31, 2025, the latest employee count at Portal Biotech is 11.

Is Portal Biotech a funded company?

Portal Biotech is a funded company, having raised a total of $45.4M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 16, 2021.

How much is Portal Biotech worth?

The latest valuation of Portal Biotech is £***** as of Apr 17, 2025.

When was the latest funding round of Portal Biotech?

Portal Biotech's latest funding was a $***** Series A round on Apr 17, 2025, with participation from 10 investors. Its primary sector is Life Sciences Platforms and Tools. In United Kingdom, the Life Sciences Platforms and Tools sector has seen $128M in funding in 2026 to date.

Where does Portal Biotech rank among its competitors?

Portal Biotech ranks 2nd amongst 15 active competitors, of which 9 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Pictor, which secured $7.5M in Jun, 2026.

Who are the top competitors of Portal Biotech?

Portal Biotech's top competitors include NanoMosaic, 10x Science and Inanovate. Among them, Pictor secured the most recent funding round in June, 2026.

Portal Biotech - 2026 Company Profile, Team, Funding, Competitors & Financials

Portal Biotech is a series A company based in London (United Kingdom), founded in 2021 by Andrew Heron and Giovanni Maglia. It operates as a Developer of biosensing technology that utilizes bioengineered nanopores to analyze proteins and metabolomics. Portal Biotech has raised $45.4M in funding from Earlybird and NIF, with a current valuation of £*****. The company has 15 active competitors, including 9 that are funded. Its top competitors include companies like NanoMosaic, 10x Science and Inanovate.

Company Details

Developer of biosensing technology that utilizes bioengineered nanopores to analyze proteins and metabolomics. It offers bench-top nanopore solutions for comprehensive, full–length, single-molecule protein characterisation which enables the real-time analysis of complex mixtures of biomolecules, providing rapid insights into protein abundance, identity, heterogeneity and variation.

Website: www.portalbiotech.com/
Email ID: *****@portalbiotech.com, *****@portalbiotech.com
Registered Address: 38 SWINBURNE ROAD,ABINGDON,ENGLAND,OX14 2HD

Key Metrics

Founded Year

2021

Location

London, United Kingdom

Stage

Series A

Total Funding

$45.4M in 3 rounds

Latest Funding Round

Series A, Apr 17, 2025, $*****

Post Money Valuation

£***** as on Apr 17, 2025

Investors

Earlybird & 11 more

Ranked

2^nd among 15 active competitors

Employee Count

11 as on Mar 31, 2025

Similar Companies

NanoMosaic & 13 more

View Portal Biotech's full profile

Portal Biotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PORTAL BIOTECH LIMITED CIN: 13304359 , United Kingdom, Active	Mar 29, 2021	-	11 (As on Mar 31, 2025)

Portal Biotech has raised a total funding of $45.4M over 3 rounds. Its first funding round was on Jul 16, 2021. Its latest funding round was a Series A round on Apr 17, 2025 for $*****. 10 investors participated in its latest round. Portal Biotech has 12 institutional investors.

Here is the list of recent funding rounds of Portal Biotech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 17, 2025	6868526	Series A	1818971	4317083	7362584	1566319
Jul 15, 2022	8758866	Series A	2246278	6148525	9063923	8523870
Jul 16, 2021	4955202	Seed	4063545	2345917	1917820	3823643

Access funding benchmarks and valuations. Sign up today!

View details of Portal Biotech's funding rounds and investors

The founders of Portal Biotech are Andrew Heron and Giovanni Maglia. Andrew Heron is the CEO of Portal Biotech.

Here are the details of Portal Biotech's key team members:

Andrew Heron: Co-Founder & CEO of Portal Biotech. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Giovanni Maglia: Co-Founder of Portal Biotech.
Contact Info: 1 email address

View details of Portal Biotech's Founder profiles and Board Members

Portal Biotech's employee count trend

Portal Biotech has 11 employees as of Mar 25. The total employee count is 83.0% more than what it was in Mar 24. Here is Portal Biotech's employee count trend over the years:

Uncover Portal Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Portal Biotech include NanoMosaic, 10x Science and Inanovate. Here is the list of Top 10 competitors of Portal Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NanoMosaic 2018, Woburn (United States), Series A	Manufacturer of system for early disease detection and prognosis	$44.8M	RA Capital Management, Pura Vida Investments ... & 3 others	54/100
2nd	Portal Biotech 2021, London (United Kingdom), Series A	Developer of biosensing technology that utilizes bioengineered nanopores to analyze proteins and metabolomics	$45.4M	Earlybird, Pillar VC & 10 others	51/100
3rd	10x Science 2025, San Francisco (United States), Seed	Provider of AI-native protein characterization platform for biopharma	$5.3M	Initialized Capital, Y Combinator & 1 others	42/100
4th	Inanovate 2006, Durham (United States), Series C	Provider of multiplexed protein quantification platform for clinical diagnostics and research	$13M	Badlands Capital, America’s Seed Fund & 3 others	42/100
5th	ProteoWise 2018, New Haven (United States), Series A	Provider of a platform for the analysis of proteomics	$8.6M	Connecticut Innovations, UniWill Ventures ... & 3 others	40/100
6th	Atantares 2020, Cambridge (United States), Seed	Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies	$14M	Asia Green Fund, Qiming Venture Partners & 6 others	39/100
7th	Novilytic 2021, West Lafayette (United States), Seed	Developer of molecular recognition system to detect the quality of medicines	$3.08M	Elevate Ventures, Purdue Foundry & 3 others	38/100
8th	Pictor 2025, Carlsbad (United States), Series A	Developer of platforms for targeted protein analysis and diagnostic testing	$30M	-	30/100
9th	GenNext Technologies 2016, Montara (United States), Funding Raised	Developer of a device for protein structural analysis	-	HHS	29/100
10th	Protein Stable 2019, Leatherhead (United Kingdom), Unfunded	Provider of protein stability measurement systems for research labs	-	-	25/100